MPM BioImpact overview
Stories about MPM BioImpact
Consortium invests $145m in specialty pharma
MPM Capital and LLR Partners have led a Series D financing round totaling $50 million in equity and $95 million in debt for acute-care company EKR Therapeutics.
MPM nets big return on Idenix exit
The US life sciences investor has sold the hepatitis and HIV treatment company to Novartis in a deal that values the business at up to $612m.
MPM closes $900M Health Fund III
The US-German healthcare investor has closed its third fund on $900m, making it one of the largest funds ever raised in the sector.
MPM BioImpact contact information
Offices
399 Boylston Street, Suite 1100, Boston, 02116, United StatesContacts
| Name | Job title | Location | |
|---|---|---|---|
Key Contact Dr. Ansbert Gadicke | Job titleManaging Partner | LocationBoston, United States | Email  ------- |
| Mr. Brendan Furey | Job titleChief Compliance Officer | LocationBoston, United States | Email ----- |
| Dr. Christiana Bardon | Job titleManaging Partner | LocationBoston, United States | Email ----- |
| Mr. John Baclawski | Job titlePartner and Head of Capital Formation | LocationBoston, United States | Email ------ |
MPM BioImpact funds managed
Closed funds: 10
| Fund | Fund size | Close date | Strategy |
|---|---|---|---|
Fund size --------- | Close dateFeb 2024 | Strategy ------ | |
Fund size ----------- | Close dateFeb 2020 | Strategy ----- | |
Fund size ------- | Close dateFeb 2019 | Strategy ------ | |
Stories that mention MPM BioImpact
Haynes & Boone's fund financing report in six charts
Sub line margins rose 17% last year as fund financing becomes more lender-friendly, according to Haynes & Boone’s Fund Finance Annual Report 2023.
Fund finance market still reeling from US bank collapses
Private markets CFOs are navigating a fund finance market in flux in the wake of the regional banking crisis.
Fisher Lynch bolsters IR, legal teams
The firm has added director of investor relations Kristie Goodman and director of administration and legal affairs Dana O’Brien, both newly created positions.
NEA hires former XM Radio chief
Hugh Panero, former chief executive of the satellite radio company, is the latest in a string of high-profile appointments the Maryland-based venture firm has made over the last year.
NEA boosts ‘venture growth’ team with two hires
Silicon Valley-based New Enterprise Associates has recruited Morgan Stanley's Tony Florence and MPM Capital's Paul Walker to bolster its large-scale investment team.
CalPERS makes $718m in commitments
The $253 billion California pension fund made a fresh round of commitments to record-setting healthcare- and life science-focussed VC funds in addition to CVC and KKR.
Third Rock closes debut fund on $378m(3)
Newly formed venture firm Third Rock Ventures will use its first fund for investments in early stage biotechnology companies.
Third Rock closes debut fund on $378m(2)
Newly formed venture firm Third Rock Ventures will use its first fund for investments in early stage biotechnology companies.